Clinical Trials Logo

Clinical Trial Summary

A pharmacoimaging study of oxytcoin in antisocial personality disorder and psychopathy


Clinical Trial Description

Using a double-blinded, placebo controlled design, we explored similarities and differences in i) an important component of empathic processing (neural response to facial emotional expressions) and ii) decision-making in violent men with ASPD+/-Psychopathy, compared to healthy non-offenders (NO; n= 21 across studies), with placebo and after acute application of intranasal oxytocin, using functional Magnetic Resonance Imaging (fMRI). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05383300
Study type Interventional
Source King's College London
Contact
Status Completed
Phase N/A
Start date May 1, 2017
Completion date December 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT00060788 - Antisocial Behavior: Passing From Parent to Child to Grandchild N/A
Active, not recruiting NCT04695132 - Illness Management and Recovery- a Cluster Randomized Controlled Trial Within a Forensic Mental Inpatient Setting N/A
Not yet recruiting NCT04773340 - Adapting Dialectical Behavior Therapy for the Treatment of Criminal Offenders With Antisocial Personality Disorder
Terminated NCT00282165 - Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order Phase 4
Not yet recruiting NCT06176638 - Resettled Refugee Families for Healing N/A
Completed NCT04903938 - Positive Psychotheraphy and Antisocial Personality Disorder: Crime, Aggression, Anger
Enrolling by invitation NCT01354236 - Mental Health Related to School Dropout in Luxembourg N/A
Completed NCT02524171 - Justice-Involved Veterans and Moral Reconation Therapy N/A